Shawna Klahn

Purdue University West Lafayette — United States

Medicine · Health Sciences

13h-index566citations47works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Veterinary Oncology Research(37), Virus-based gene therapy research(28), Sarcoma Diagnosis and Treatment(17), Ultrasound and Hyperthermia Applications(10), Infectious Diseases and Mycology(4)

Publications47 total

Pilot Study of a Novel First-Line Protocol (THOP) for Intermediate–Large B-Cell Lymphoma in Dogs
Veterinary Sciences·2025Open Access
A review of the development of histotripsy for extremity tumor ablation with a canine comparative oncology model to inform human treatments
International Journal of Hyperthermia·2023· 8 citedOpen Access
Inhibitory checkpoint molecule <scp>mRNA</scp> expression in canine soft tissue sarcoma
Veterinary and Comparative Oncology·2023· 4 citedOpen Access
Histotripsy ablation for the treatment of feline injection site sarcomas: a first-in-cat <i>in vivo</i> feasibility study
International Journal of Hyperthermia·2023· 13 citedOpen Access
Supplementary Figure 2 from Adjuvant Sirolimus Does Not Improve Outcome in Pet Dogs Receiving Standard-of-Care Therapy for Appendicular Osteosarcoma: A Prospective, Randomized Trial of 324 Dogs
2023Open Access
Supplementary Table 1 from Adjuvant Sirolimus Does Not Improve Outcome in Pet Dogs Receiving Standard-of-Care Therapy for Appendicular Osteosarcoma: A Prospective, Randomized Trial of 324 Dogs
2023Open Access
Supplementary Table 3 from Adjuvant Sirolimus Does Not Improve Outcome in Pet Dogs Receiving Standard-of-Care Therapy for Appendicular Osteosarcoma: A Prospective, Randomized Trial of 324 Dogs
2023Open Access
Supplementary Figure 1 from Adjuvant Sirolimus Does Not Improve Outcome in Pet Dogs Receiving Standard-of-Care Therapy for Appendicular Osteosarcoma: A Prospective, Randomized Trial of 324 Dogs
2023Open Access
Supplementary Table 1 from Adjuvant Sirolimus Does Not Improve Outcome in Pet Dogs Receiving Standard-of-Care Therapy for Appendicular Osteosarcoma: A Prospective, Randomized Trial of 324 Dogs
2023Open Access
Supplementary Figure 1 from Adjuvant Sirolimus Does Not Improve Outcome in Pet Dogs Receiving Standard-of-Care Therapy for Appendicular Osteosarcoma: A Prospective, Randomized Trial of 324 Dogs
2023Open Access
Data from Adjuvant Sirolimus Does Not Improve Outcome in Pet Dogs Receiving Standard-of-Care Therapy for Appendicular Osteosarcoma: A Prospective, Randomized Trial of 324 Dogs
2023Open Access
Supplementary Table 2 from Adjuvant Sirolimus Does Not Improve Outcome in Pet Dogs Receiving Standard-of-Care Therapy for Appendicular Osteosarcoma: A Prospective, Randomized Trial of 324 Dogs
2023Open Access
Supplementary Table 4 from Adjuvant Sirolimus Does Not Improve Outcome in Pet Dogs Receiving Standard-of-Care Therapy for Appendicular Osteosarcoma: A Prospective, Randomized Trial of 324 Dogs
2023Open Access
Supplementary Table 3 from Adjuvant Sirolimus Does Not Improve Outcome in Pet Dogs Receiving Standard-of-Care Therapy for Appendicular Osteosarcoma: A Prospective, Randomized Trial of 324 Dogs
2023Open Access
Supplementary Table 2 from Adjuvant Sirolimus Does Not Improve Outcome in Pet Dogs Receiving Standard-of-Care Therapy for Appendicular Osteosarcoma: A Prospective, Randomized Trial of 324 Dogs
2023Open Access
Supplementary Table 4 from Adjuvant Sirolimus Does Not Improve Outcome in Pet Dogs Receiving Standard-of-Care Therapy for Appendicular Osteosarcoma: A Prospective, Randomized Trial of 324 Dogs
2023Open Access
Supplementary Figure 2 from Adjuvant Sirolimus Does Not Improve Outcome in Pet Dogs Receiving Standard-of-Care Therapy for Appendicular Osteosarcoma: A Prospective, Randomized Trial of 324 Dogs
2023Open Access
Data from Adjuvant Sirolimus Does Not Improve Outcome in Pet Dogs Receiving Standard-of-Care Therapy for Appendicular Osteosarcoma: A Prospective, Randomized Trial of 324 Dogs
2023Open Access
Histotripsy Ablation for the Treatment of Feline Injection Site Sarcomas: A First-in-Cat In Vivo Feasibility Study
2023Open Access
Histotripsy Ablation for the Treatment of Feline Injection Site Sarcomas: A First-in-Cat In Vivo Feasibility Study
2023Open Access
page 1 of 3Next →

Frequent Co-authors

Nikolaos Dervisis(39), Haley Leeper(16), Annette Smith(16), Daniel L. Gustafson(16), Amy K. LeBlanc(15), Christina Mazcko(15), Aswini Cherukuri(15), Erika P. Berger(15), William C. Kisseberth(15), Megan E. Brown(15), Susan E. Lana(15), Kristen Weishaar(15), Brian K. Flesner(15), Jeffrey N. Bryan(15), David M. Vail(15), Jenna H. Burton(15), Jennifer L. Willcox(15), Anthony J. Mutsaers(15), J. Paul Woods(15), Nicole C. Northrup(15)